Nuzenio

Nmibc

Nmibc news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 13 latest news signals 9 publisher sources 100/100 entity strength

Latest news

Overcoming Barriers to Intravesical Gemcitabine System in High-Risk NMIBC - CancerNetworkCancerNetwork · Sat, 08 Aug 2026 12:09:17 GMT Extending Drug Exposure Without Systemic Toxicity in NMIBC Treatment - CancerNetworkCancerNetwork · Fri, 07 Aug 2026 19:09:52 GMT Changing Chemotherapy Delivery in BCG-Unresponsive Bladder Cancer - CancerNetworkCancerNetwork · Fri, 07 Aug 2026 18:09:52 GMT Tyra Biosciences Reports Second Quarter 2026 Financial Results and Recent Highlights - TradingViewTradingView · Tue, 04 Aug 2026 20:05:00 GMT enGene to Host Virtual KOL Event to Discuss Emerging Non-Muscle Invasive Bladder Cancer (NMIBC) Market Insights, on August 11, 2026 - Business WireBusiness Wire · Tue, 04 Aug 2026 12:00:00 GMT Forlong Biotechnology Announces Successful Completion of GMP Pivotal Batch Production for FL115 (IL-15 Superagonist), Ready to Support Upcoming Phase III Clinical Trial in Non-Muscle Invasive Bladder Cancer (NMIBC) - Business WireBusiness Wire · Mon, 03 Aug 2026 12:00:00 GMT Redefining High-Risk NMIBC - EMJEMJ · Sat, 01 Aug 2026 01:07:30 GMT Oncology Pulsepoint: How Clinicians Should Navigate New Bladder-Preserving Therapies for NMIBC - Pharmacy TimesPharmacy Times · Thu, 30 Jul 2026 19:03:17 GMT

Timeline

Sat, 08 Aug 2026 12:09:17 GMTOvercoming Barriers to Intravesical Gemcitabine System in High-Risk NMIBC - CancerNetwork

Fri, 07 Aug 2026 19:09:52 GMTExtending Drug Exposure Without Systemic Toxicity in NMIBC Treatment - CancerNetwork

Fri, 07 Aug 2026 18:09:52 GMTChanging Chemotherapy Delivery in BCG-Unresponsive Bladder Cancer - CancerNetwork

Tue, 04 Aug 2026 20:05:00 GMTTyra Biosciences Reports Second Quarter 2026 Financial Results and Recent Highlights - TradingView

Tue, 04 Aug 2026 12:00:00 GMTenGene to Host Virtual KOL Event to Discuss Emerging Non-Muscle Invasive Bladder Cancer (NMIBC) Market Insights, on August 11, 2026 - Business Wire

Mon, 03 Aug 2026 12:00:00 GMTForlong Biotechnology Announces Successful Completion of GMP Pivotal Batch Production for FL115 (IL-15 Superagonist), Ready to Support Upcoming Phase III Clinical Trial in Non-Muscle Invasive Bladder Cancer (NMIBC) - Business Wire

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

BCG8 live mentions Cancer7 live mentions Muscle Invasive Bladder6 live mentions Marketing Authorization3 live mentions Unresponsive NMIBC3 live mentions Intravesical Gemcitabine System2 live mentions High2 live mentions Risk NMIBC2 live mentions CancerNetwork2 live mentions Unresponsive Bladder Cancer2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Nmibc.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.